David D O'Toole Insider Trading $OPNT OPIANT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for David D O'Toole.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of David D O'Toole. David D O'Toole is Chief Financial Officer in RESPONSE GENETICS INC ($RGDX) and Vice President & CFO in RESPONSE GENETICS INC ($RGDX) and Chief Financial Officer in OPIANT PHARMACEUTICALS, INC. ($OPNT) and Chief Financial Officer in Capnia, Inc. ($CAPN) and See Remarks in Capnia, Inc. ($CAPN) and SVP & Chief Financial Officer in Capnia, Inc. ($CAPN).

David D O'Toole in OPIANT PHARMACEUTICALS, INC.

Trading Symbol: OPNT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David D O'Toole: Chief Financial Officer
Holdings: 17,815 shares
Current Value: $139,135
Latest Transaction: Jan 27 2021
$OPNT Market Capitalization: $15.43M
$OPNT Previous Close: $7.81

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of David D O'Toole in OPIANT PHARMACEUTICALS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, OPNT, RGDX, SLNO

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Option Exercise	A	12.15	10,750	130,613	10,750
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Grant	A	0.00	5,400	0	23,215	17.8 K to 23.2 K (+30.31 %)
Jan 27 2021	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Grant	A	0.00	2,450	0	17,815	15.4 K to 17.8 K (+15.95 %)
Jun 11 2020	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	8.74	1,000	8,740	15,365	14.4 K to 15.4 K (+6.96 %)
May 26 2020	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	11.00	1,000	11,000	14,365	13.4 K to 14.4 K (+7.48 %)
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Option Exercise	A	13.60	8,250	112,200	8,250
Jan 09 2020	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Grant	A	0.00	4,150	0	13,365	9.2 K to 13.4 K (+45.04 %)
Nov 26 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	13.22	100	1,322	9,215	9.1 K to 9.2 K (+1.10 %)
Nov 15 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	15.00	100	1,500	9,115	9 K to 9.1 K (+1.11 %)
Nov 15 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	14.91	1,000	14,910	9,015	8 K to 9 K (+12.48 %)
Aug 15 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	15.20	1,000	15,200	8,015	7 K to 8 K (+14.26 %)
Aug 15 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	15.20	1,000	15,200	8,015	7 K to 8 K (+14.26 %)
Aug 13 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	15.46	1,000	15,460	7,015	6 K to 7 K (+16.63 %)
Jan 04 2019	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Option Exercise	A	13.61	33,000	449,130	33,000
May 16 2018	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	16.95	2,000	33,900	5,000	3 K to 5 K (+66.67 %)
May 14 2018	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Buy	P	18.85	3,000	56,550	3,000	0 to 3 K
Jan 08 2018	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Option Exercise	A	24.84	13,200	327,888	13,200
Sep 14 2017	OPNT	OPIANT PHARMACEUTI ...	O'Toole David D	Chief Financial Off ...	Option Exercise	A	36.00	150,000	5,400,000	150,000

Page: 1